What is the difference between surgical and non-surgical spine treatment?
Non-surgical spine treatments address disc-related pain without incisions or permanent structural changes to the spine. Surgical options — such as discectomy or fusion — remove or immobilize spinal segments. For patients with chronic pain from annular tears or disc degeneration, non-surgical approaches are often evaluated first.
For patients with chronic disc-related back or neck pain, the treatment landscape can feel like a binary: invasive surgery or treatments that manage symptoms without resolving the underlying problem. A third category — biologic disc repair — exists between those two poles and is the focus of this FAQ. For a broader framework on evaluating your options, see our guide on how to evaluate non-surgical spine treatment options.
What is intra-annular fibrin injection?
Intra-annular fibrin injection is a minimally invasive procedure that uses an FDA-approved fibrin sealant to seal tears in the outer wall of a spinal disc. It is performed under imaging guidance, completed in under an hour, and requires no surgical incisions.
The procedure targets the annular tears — damage to the disc’s tough outer ring — that are often the structural source of chronic discogenic pain. The fibrin sealant, derived from human plasma and FDA-approved as a sealant, is delivered through a thin catheter directly into the disc. Once in place, it acts as a biologic scaffold: sealing the tear and supporting the disc’s natural healing processes. Most patients walk within 30 minutes of the procedure and return home the same day.
The fibrin sealant used in the procedure is FDA-approved as a sealant. Specific clinical applications, candidacy, and outcomes vary by patient.
How does fibrin disc treatment differ from steroid injections?
Steroid injections reduce inflammation and offer temporary symptom relief. Fibrin disc treatment is designed to structurally seal the annular tear — the underlying source of the pain — rather than suppress the inflammatory response around it.
Epidural steroid injections deliver corticosteroid medication into the space around the spinal cord to reduce nerve irritation. According to an AAFP systematic review, epidural steroid injections are not effective for chronic low back pain. They do not repair the disc itself. Intra-annular fibrin injection, by contrast, directly targets the structural defect — the tear in the annulus — with the goal of sealing it and restoring disc integrity. For a detailed comparison, see lumbar epidural steroid injection vs. regenerative biologics.
Why do some patients choose biologic disc repair over spinal fusion?
Spinal fusion permanently joins two or more vertebrae, altering spinal mechanics and requiring significant recovery time. Biologic disc repair is designed to preserve the natural disc structure and support healing, with no permanent anatomical changes and a shorter recovery.
Traditional fusion surgery immobilizes the treated spinal segment, which can shift mechanical stress to adjacent levels over time. The fibrin procedure, by contrast, is an outpatient approach intended to restore disc function rather than eliminate motion. For patients who are not surgical candidates or who want to avoid permanent spinal changes, biologic disc repair represents a structurally different philosophy of care. For a detailed side-by-side, see fibrin disc treatment vs. spinal fusion: patient FAQ. For a broader look at why some patients choose this path, see 8 reasons patients choose regenerative spine care over traditional operations.
Clinical Note
We see a consistent pattern among patients who come to us: they have tried physical therapy, gone through rounds of injections, and were told that fusion is the logical next step. Many are not opposed to getting better — they are opposed to a permanent, irreversible intervention when they are not certain it will resolve the pain. What we hear most often is that no one has explained what is actually torn, why it hurts, and what a non-surgical repair option would look like. That conversation is what we are here to have.
How does fibrin injection compare to PRP for disc pain?
Both fibrin injection and platelet-rich plasma (PRP) are considered biologic approaches, but they work differently. Fibrin injection provides a structural sealant that physically closes annular tears. PRP introduces concentrated growth factors to stimulate tissue repair but does not provide the same mechanical sealing function.
In outcomes data, PRP achieved 50% or greater pain relief at 6 months in approximately 47% of patients studied. Fibrin injection outcome registries tracking more than 7,000 procedures with long-term follow-up report an 83% success rate; individual outcomes vary. The two approaches are not interchangeable for all disc pathologies — a clinical evaluation is the only way to determine which, if either, is appropriate for a specific patient’s disc anatomy. See PRP vs. intra-annular fibrin injection: which is better for non-surgical spine treatment? for a full comparison.
What conditions does biologic disc repair address?
Biologic disc repair through intra-annular fibrin injection is designed for chronic low back or neck pain that originates from structural disc damage — specifically annular tears and disc degeneration with preserved disc height.
The most common presentations include degenerative disc disease and symptomatic annular tears in which the disc’s inner material presses on or leaks toward adjacent nerves. The procedure is not indicated for acute trauma, spinal tumors, fractures, neurological emergencies, or pain that is not disc-related in origin. A clinical evaluation — including MRI review — is the only way to determine whether a patient’s anatomy and symptom profile make them an appropriate candidate.
Who is a candidate for intra-annular fibrin injection?
Candidacy is determined through a clinical evaluation, not a checklist. Patients who have not responded to conservative care — physical therapy, medications, or injections — and who want to avoid surgery are among those who seek evaluation. A recent MRI is required to assess disc anatomy.
Among the characteristics that typically emerge in evaluations for this procedure: chronic discogenic pain lasting beyond conservative treatment timelines, identifiable annular tears on imaging, and adequate remaining disc height. Patients who have already undergone spinal surgery without adequate relief — a condition sometimes called failed back surgery syndrome — are also evaluated, as outcome data suggests 80% of failed surgery patients reported positive outcomes with fibrin injection; individual outcomes vary. A clinical evaluation is the only way to know for certain whether the procedure is appropriate. For guidance on building a treatment approach when surgery is not the preferred path, see how to choose the right back pain treatment.
Is there a diagnostic step before treatment?
Yes. An annulogram is typically performed before treatment. This imaging-guided diagnostic procedure identifies every disc tear and leak present before any therapeutic injection is planned.
The annulogram allows the clinical team to confirm which discs are structurally compromised and map the precise location of tears. This step is what distinguishes the fibrin approach from non-targeted injections — treatment is guided by structural findings, not symptom pattern alone. MRI review is the starting point; the annulogram provides the pre-treatment roadmap.
Frequently Asked Questions
Does back surgery always work better than non-surgical treatment?
Not for all patients. Back surgery has roughly a 40% failure rate — a documented outcome known as Failed Back Surgery Syndrome. Non-surgical options, including biologic disc repair, are designed to address disc pathology without permanent structural alteration. The right approach depends on the specific diagnosis, anatomy, and treatment history of the individual patient.
How long does recovery take after intra-annular fibrin injection?
The procedure is performed on an outpatient basis, typically completed in under an hour. Most patients walk within 30 minutes and return home the same day. Activity restrictions and return-to-work timelines vary by individual and are discussed during the clinical evaluation process.
Is the fibrin sealant FDA-approved?
The fibrin sealant used in the procedure is FDA-approved as a sealant. It is manufactured by Baxter Pharmaceuticals and delivered under imaging guidance. Specific clinical applications, candidacy, and individual outcomes vary by patient and clinical context.
Can veterans access this procedure through the VA?
The fibrin procedure may be a covered VA benefit under the Mission Act when the VA cannot provide timely or appropriate care. Valor works directly with VA referral coordinators and handles the paperwork on the patient’s behalf. VA coverage is determined case-by-case by the VA, not by Valor Spine.
What if I’ve already had back surgery and still have pain?
Patients with persistent pain after prior spine surgery are evaluated for the fibrin procedure. Outcome data from procedure registries indicates that 80% of failed surgery patients reported positive outcomes with fibrin injection; individual outcomes vary. A clinical evaluation and MRI review are required to assess whether residual disc pathology is present and addressable.
How do I find out if I’m a candidate?
A clinical evaluation — beginning with a no-cost MRI review — is the starting point. A clinical evaluation is the only way to know for certain whether the procedure is appropriate for your anatomy and symptom history. Schedule a consultation to begin the process.
This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.
